Home › NDC Lookup › RxCUI directory › RxCUI 1734086

20 ML ropivacaine hydrochloride 10 MG/ML Injection [Naropin] — RxCUI 1734086

RxNorm drug concept · Semantic branded drug
RxCUI 1734086 Semantic branded drug · SBD ● Current RxNorm concept 8 FDA products 25 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1734086
Official name20 ML ropivacaine hydrochloride 10 MG/ML Injection [Naropin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNaropin 1 % per 20 ML Injection; Naropin 1 % in 20 ML Injection; 20 ML Naropin 10 MG/ML Injection; Naropin 200 MG per 20 ML Injection
FDA products mapped8
Package NDCs mapped25
Reported Medicaid activity (SDUD)17,835 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ropivacaine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ropivacaine is a local anesthetic — it temporarily blocks pain signals in a specific part of your body. You might be receiving it to keep you comfortable and pain-free during surge...
  • What is ropivacaine actually used for? Why am I getting it?
  • It depends on the dose and concentration used. Ropivacaine blocks pain first, then temperature, then touch, and at higher concentrations it can reduce muscle movement too. For labo...
  • Will I be completely numb — can I move at all?
📖 Read our full Ropivacaine guide →

🕸️ Concept Web — How 20 ML ropivacaine hydrochloride 10 MG/ML Injecti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 20 ML ropivacaine hydrochloride 10 MG/ML Injection [Naropin] RxCUI 1734086

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ropivacaine 35780
    • Ropivacaine hydrochloride 236539
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Naropin 134802
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ropivacaine Injection 1734083
    • Ropivacaine hydrochloride Injection 2646704
    • Ropivacaine Injectable Product 1157986
    • Ropivacaine hydrochloride Injectable Product 2661044
    • Ropivacaine Injection [Naropin] 1734085
    • Ropivacaine hydrochloride Injection [Naropin] 2655521
    • Naropin Injectable Product 1179322
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 20 ML ropivacaine hydrochloride 10 MG/ML Injection SCD · 1734084
  • Ropivacaine hydrochloride 10 MG/ML SCDC · 905176
  • Ropivacaine Injection SCDF · 1734083
  • Ropivacaine hydrochloride Injection SCDFP · 2646704
  • Ropivacaine Injectable Product SCDG · 1157986
  • Ropivacaine hydrochloride Injectable Product SCDGP · 2661044

Brand-Name Concepts

  • Ropivacaine hydrochloride 10 MG/ML [Naropin] SBDC · 905178
  • Ropivacaine Injection [Naropin] SBDF · 1734085
  • Ropivacaine hydrochloride Injection [Naropin] SBDFP · 2655521
  • Naropin Injectable Product SBDG · 1179322
  • Naropin BN · 134802

📦 FDA Products & Package NDCs

8 products · 25 package NDCs
25 package NDCs map to RxCUI 1734086 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63323-0285-10 5 AMPULE in 1 BOX (63323-285-10) / 10 mL in 1 AMPULE (63323... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-13 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-285-13) / 10 mL in... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-20 5 AMPULE in 1 BOX (63323-285-20) / 20 mL in 1 AMPULE (63323... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-23 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-285-23) / 20 mL in... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-61 24 BAG in 1 CASE (63323-285-61) / 100 mL in 1 BAG (63323-28... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-63 24 BAG in 1 CASE (63323-285-63) / 200 mL in 1 BAG (63323-28... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-64 12 BOTTLE in 1 CASE (63323-285-64) / 200 mL in 1 BOTTLE (63... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-65 12 BOTTLE in 1 CASE (63323-285-65) / 100 mL in 1 BOTTLE (63... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0285-67 12 BOTTLE in 1 CASE (63323-285-67) / 100 mL in 1 BOTTLE (63... Naropin Fresenius Kabi USA, LLC 2009-08-04
63323-0286-00 12 BOTTLE in 1 CASE (63323-286-00) / 100 mL in 1 BOTTLE (63... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0286-20 5 AMPULE in 1 BOX (63323-286-20) / 20 mL in 1 AMPULE (63323... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0286-23 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-23) / 20 mL in... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0286-30 1 VIAL, SINGLE-DOSE in 1 BOX (63323-286-30) / 30 mL in 1 VI... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0286-31 5 VIAL, SINGLE-DOSE in 1 BOX (63323-286-31) / 30 mL in 1 VI... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0286-35 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-35) / 30 mL in... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0286-63 12 BOTTLE in 1 CASE (63323-286-63) / 200 mL in 1 BOTTLE (63... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0286-95 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-286-95) / 30 mL in 1... Naropin Fresenius Kabi USA, LLC 2009-08-04
63323-0287-20 5 AMPULE in 1 BOX (63323-287-20) / 20 mL in 1 AMPULE (63323... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0287-21 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-287-21) / 20 mL in... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0288-10 5 AMPULE in 1 BOX (63323-288-10) / 10 mL in 1 AMPULE (63323... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0288-11 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-288-11) / 10 mL in... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0288-20 5 AMPULE in 1 BOX (63323-288-20) / 20 mL in 1 AMPULE (63323... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0288-21 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-288-21) / 20 mL in... Naropin Fresenius Kabi USA, LLC 2011-05-31
63323-0288-27 5 AMPULE in 1 BOX (63323-288-27) / 20 mL in 1 AMPULE (63323... Naropin Fresenius Kabi USA, LLC 2009-08-04
63323-0288-29 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-288-29) / 20 mL in 1... Naropin Fresenius Kabi USA, LLC 2009-08-04
Observed labelers: Fresenius Kabi USA, LLC (25) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2795 Ropivacaine hcl injection 23 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.